Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun:68:103426.
doi: 10.1016/j.ebiom.2021.103426. Epub 2021 Jun 13.

In response to the letter to the editor by Soha Ghanian et al. re our publication "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"

Affiliations
Comment

In response to the letter to the editor by Soha Ghanian et al. re our publication "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males"

Andrea M Isidori et al. EBioMedicine. 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no competing interests.

Comment on

References

    1. Cadegiani FA, McCoy J, Gustavo Wambier C, Goren A. Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and time-to-remission in males with COVID-19: a randomized, double-blind, placebo-controlled interventional trial (EAT-DUTA AndroCoV Trial - Biochemical) Cureus. 2021;13:e13047. - PMC - PubMed
    1. Farina N, Ramirez GA, De Lorenzo R, Di Filippo L, Conte C, Ciceri F, Manfredi AA, Rovere-Querini P. COVID-19: pharmacology and kinetics of viral clearance. Pharmacol Res. 2020 Nov;161 doi: 10.1016/j.phrs.2020.105114. - DOI - PMC - PubMed
    1. Baldassarri M. Shorter androgen receptor polyQ alleles protect against life- threatening COVID-19 disease in European males. EBioMedicine. 2021 - PMC - PubMed
    1. Klein EA, Li J, Milinovich A, Schold JD, Sharifi N, Kattan MW, Jehi L. Androgen deprivation therapy in men with prostate cancer does not affect risk of infection with SARS-CoV-2. J Urol. 2021 Feb;205(2):441–443. doi: 10.1097/JU.0000000000001338. Epub 2020 Sep 8. PMID: 32897764. - DOI - PubMed
    1. McCoy J. Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients. J Eur Acad Dermatol. Venereol. 2020;35(1):e15–e17. - PMC - PubMed